PMID: 2485283Jan 1, 1988Paper

Relapse prevention versus broad spectrum treatment for smoking cessation: a comparison of efficacy

Journal of Substance Abuse
K M EmmonsG Weidner

Abstract

The efficacy of a smoking cessation relapse prevention (RP) program, emphasizing cognitive-behavioral coping skills, was compared to that of a broad spectrum (BS) program, which emphasized behavioral skills. It was hypothesized that the RP program would be more effective in producing long-term abstinence, compared to the BS package. Abstinence rates validated by saliva thiocyanate and carbon monoxide, as well as self-report of smoking reduction, were measured at posttreatment, 3 and 6 months. No differences in posttreatment quit rates were found between the two groups, although both programs produced significantly higher quit rates than the wait-list control group. Contrary to prediction, the BS group produced marginally significantly greater abstinence at 3 months. No differences in abstinence were found at 6 months. Reduction in cigarette consumption was marginally significantly greater for the BS group at 3 and 6 months. Various mediators of treatment outcome were not found to influence success in quitting. There was a significant weight gain in those who quit.

References

Sep 29, 1976·Psychopharmacology·P OhlinH Westling
Jun 1, 1977·Journal of Consulting and Clinical Psychology·H A Lando
Jan 1, 1987·Addictive Behaviors·R P PintoS I Jacobus
Jan 1, 1986·Addictive Behaviors·J R Davis, A G Glaros
Jan 1, 1986·Addictive Behaviors·S Shiffman
Oct 1, 1971·Journal of Clinical Psychology·W A HuntL G Branch
Dec 1, 1966·American Journal of Public Health and the Nation's Health·S S Tomkins
Nov 23, 1984·JAMA : the Journal of the American Medical Association·A I Hjalmarson
Jan 1, 1984·Addictive Behaviors·S J Schneider
Apr 1, 1984·Journal of Consulting and Clinical Psychology·R A BrownJ Harrington-Kostur
Jul 1, 1981·Preventive Medicine·A W CaggiulaG Widdowson
Feb 1, 1982·Journal of Consulting and Clinical Psychology·S Shiffman
Sep 1, 1982·Journal of Behavioral Medicine·K O Fagerström
Dec 1, 1981·American Journal of Public Health·R V LuepkerD R Jacobs

❮ Previous
Next ❯

Citations

Dec 1, 1989·Journal of Behavioral Medicine·K M EmmonsR L Collins
Jan 1, 1992·Addictive Behaviors·K M EmmonsR L Collins
Jan 1, 1994·Drug and Alcohol Review·A J BaillieP Webster
Sep 25, 2008·BMC Public Health·Michael UssherIsaac Manyonda
Sep 22, 2006·Journal of the American Podiatric Medical Association·Jeffrey P HallRaymond M Yong
Aug 22, 2013·The Cochrane Database of Systematic Reviews·Peter HajekTim Lancaster
Feb 14, 2019·The Cochrane Database of Systematic Reviews·Jonathan Livingstone-BanksPeter Hajek
Oct 1, 2019·The Cochrane Database of Systematic Reviews·Nicola LindsonPaul Aveyard
Nov 7, 2019·The Cochrane Database of Systematic Reviews·Jonathan Livingstone-BanksPeter Hajek

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Cochrane Database of Systematic Reviews
Peter HajekM Jarvis
The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
Cheryl OnckenHenry R Kranzler
© 2022 Meta ULC. All rights reserved